MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales Of Cortrophin
Gel
$75,119K
Sales Of ILUVIENAnd
YUTIQ
$19,255K
Total Sales Of Rare
Disease Pharmaceutical...
$94,374K
Sales Of Established
Brand Royalties And...
$21,540K
Sales Of Established
Brands
$12,328K
Sales Of Generic
Pharmaceutical Products
$105,402K
Sales Of Generic Other
Revenues
$3,818K
Total Sales Of Rare
Disease And Brands
$128,242K
Total Sales Of
Generics And Other
$109,220K
Net revenues
$237,462K
Operating income
$38,888K
Unrealized loss (gain) on
investment in equity...
$5,753K
Total operating
expenses, net
$198,574K
Contingent consideration
fair value...
-$182K
Income before income
tax expense
$40,221K
Interest expense, net
-$3,769K
Other (expense)
income, net
-$651K
Cost of sales
(excluding depreciation...
$93,582K
Selling, general, and
administrative
$73,655K
Depreciation and
amortization
$20,919K
Research and development
$10,600K
Net income
$29,492K
Income tax expense
$10,729K
Net income
available to common...
$29,492K
Back
Back
Income Statement
source: myfinsight.com
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)